Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) FCF Payout Ratio (2020 - 2024)

Maravai Lifesciences Holdings has reported FCF Payout Ratio over the past 5 years, most recently at 0.0 for Q4 2024.

  • Quarterly results put FCF Payout Ratio at 0.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was 0.01 (up 27.39% YoY), and the annual figure for FY2024 was 0.02, down 114.06%.
  • FCF Payout Ratio for Q4 2024 was 0.0 at Maravai Lifesciences Holdings, down from 0.11 in the prior quarter.
  • Over the last five years, FCF Payout Ratio for MRVI hit a ceiling of 1.91 in Q4 2021 and a floor of 0.0 in Q3 2020.
  • Median FCF Payout Ratio over the past 5 years was 0.25 (2022), compared with a mean of 0.4.
  • Biggest five-year swings in FCF Payout Ratio: surged 14979.45% in 2021 and later crashed 85.12% in 2022.
  • Maravai Lifesciences Holdings' FCF Payout Ratio stood at 1.27 in 2020, then surged by 50.34% to 1.91 in 2021, then crashed by 85.12% to 0.28 in 2022, then crashed by 81.15% to 0.05 in 2023, then crashed by 92.91% to 0.0 in 2024.
  • The last three reported values for FCF Payout Ratio were 0.0 (Q4 2024), 0.11 (Q2 2024), and 0.05 (Q2 2023) per Business Quant data.